E-LIB Suche - Ergebnisse für: Gini, G.

1

Primary Mediastinal B‐cell Lymphoma, a nationwide real‐life..:

Iannitto, E. ; Balzarotti, M. ; Martelli, M....
Hematological Oncology. 41 (2023) S2 - p. 408-410 , 2023

Link: https://doi.org/10.1002/..

2

MYC ALTERATIONS IN HIV‐ASSOCIATED B CELL LYMPHOMAS: RESULTS..:

Pagani, C. ; Rusconi, C. ; Pria, A. Dalla...
Hematological Oncology. 41 (2023) S2 - p. 653-654 , 2023

Link: https://doi.org/10.1002/..

3

FERTILITY PRESERVATION IN ADULT LYMPHOMA PATIENTS: A CONSEN..:

Minoia, C. ; Viviani, S. ; Silvestris, E....
Hematological Oncology. 41 (2023) S2 - p. 678-679 , 2023

Link: https://doi.org/10.1002/..

4

VACCINATION STRATEGIES FOR PATIENTS WITH LYMPHOMA: A REAL‐W..:

Annibali, O. ; Mancuso, S. ; Minoia, C....
Hematological Oncology. 41 (2023) S2 - p. 823-823 , 2023

Link: https://doi.org/10.1002/..

5

PB2132: COPANLISIB PLUS RITUXIMAB-BENDAMUSTINE FOR RELAPSED..:

Novo, M. ; Castellino, A. ; Chiappella, A....
HemaSphere. 6 (2022) - p. 2003-2004 , 2022

Link: https://doi.org/10.1097/..

6

PHASE II TRIAL OF RITUXIMAB PLUS CHLORAMBUCIL FOLLOWED BY A..:

Pirosa, M. C. ; Orsucci, L. ; Feugier, P....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

7

LATE TOXICITIES AND LONG‐TERM MONITORING IN CLASSICAL HODGK..:

Minoia, C. ; Gerardi, C. ; Allocati, E....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

8

RESPONSE ADAPTED POST INDUCTION THERAPY IN FOLLICULAR LYMPH..:

Luminari, S. ; Galimberti, S. ; Versari, A....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

9

DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN LATE‐OCTOGENARIAN ..:

Tucci, A. ; Merli, F. ; Fabbri, A....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

10

THE ELDERLY PROGNOSTIC INDEX (EPI) PREDICTS EARLY MORTALITY..:

Merli, F. ; Tucci, A. ; Arcari, A....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

11

BRENTUXIMAB VEDOTIN CONSOLIDATION AFTER AUTOLOGOUS STEM CEL..:

Massaro, F. ; Pavone, V. ; Stefani, P. M....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

12

BASELINE METABOLIC TUMOR VOLUME AND IPS PREDICT ABVD FAILUR..:

Gallamini, A ; Rambaldi, A ; Patti, C...
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

13

THE ELDERLY PROJECT BY THE FONDAZIONE ITALIANA LINFOMI: A P..:

Spina, M. ; Merli, F. ; Puccini, B....
Hematological Oncology. 37 (2019) S2 - p. 248-250 , 2019

Link: https://doi.org/10.1002/..

14

OUTCOMES IN FIRST RELAPSED‐REFRACTORY YOUNGER PATIENTS WITH..:

Visco, C. ; Di Rocco, A. ; Tisi, M.C....
Hematological Oncology. 37 (2019) S2 - p. 46-47 , 2019

Link: https://doi.org/10.1002/..

15

IBRUTINIB COMPARED TO STANDARD CHEMOTHERAPY FOR CENTRAL NER..:

Rusconi, C. ; Tucker, D. ; Bernard, S....
Hematological Oncology. 37 (2019) S2 - p. 244-245 , 2019

Link: https://doi.org/10.1002/..